IGUCHI KIMI

CIK 00013048152 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001304815

Recent Transactions

50 trades

Tax Payment
Sage Therapeutics, Inc.
Common Stock
2024-08-05$8.96/sh−3,636→ 81,405 total
Award
Sage Therapeutics, Inc.
Common Stock
2024-08-05+13,500→ 85,041 total
Award
Sage Therapeutics, Inc.
Common Stock
2024-02-13+11,250→ 81,679 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-13+22,500→ 22,500 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2024-01-02−1,642→ 0 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2024-01-02$1.36/sh+1,642→ 70,429 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2023-11-28$19.27/sh−943→ 68,787 total
Award
Sage Therapeutics, Inc.
Common Stock
2023-11-28+3,500→ 69,730 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2023-03-15$1.36/sh+3,000→ 65,560 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-03-15−3,000→ 1,642 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2023-02-23$1.36/sh+250→ 62,560 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-02-23−250→ 4,642 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-02-21−750→ 4,892 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2023-02-21$1.36/sh+750→ 62,310 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-02-13+16,720→ 16,720 total
Award
Sage Therapeutics, Inc.
Common Stock
2023-02-03+2,850→ 62,474 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2023-02-03$44.16/sh−914→ 61,560 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-09−1,600→ 5,642 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2023-01-09$1.36/sh+1,600→ 59,624 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-04−1,800→ 7,242 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2023-01-04$1.36/sh+1,800→ 58,024 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-17−4,500→ 9,042 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2022-02-17$1.36/sh+4,500→ 55,600 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-11+15,200→ 15,200 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2021-11-23$1.36/sh+1,000→ 51,100 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-11-23−495→ 0 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-11-23−505→ 13,542 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-11-22−2,500→ 495 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2021-11-22$1.36/sh+2,500→ 50,100 total
Award
Sage Therapeutics, Inc.
Common Stock
2021-10-19+3,800→ 48,624 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2021-10-19$40.29/sh−1,024→ 47,600 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-16−2,000→ 14,047 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2021-06-16$1.36/sh+2,000→ 44,533 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-15−3,000→ 16,047 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2021-06-15$1.36/sh+3,000→ 39,855 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2021-06-15$58.80/sh−822→ 42,533 total
Award
Sage Therapeutics, Inc.
Common Stock
2021-06-15+3,500→ 43,355 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-04-13−948→ 0 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-04-13−552→ 2,995 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2021-04-13$1.36/sh+1,500→ 36,855 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-02-10+19,000→ 19,000 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-05−1,750→ 948 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2021-01-05$1.36/sh+1,750→ 35,355 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2020-04-30$1.36/sh+4,000→ 33,261 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-04-30−4,000→ 2,698 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-04-28+9,450→ 9,450 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-12+17,500→ 17,500 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2019-12-10$1.36/sh+500→ 29,261 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-10−500→ 3,547 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2019-12-09$1.36/sh+15,000→ 28,761 total

Companies

Recent Filings

Address

C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET

CAMBRIDGE, MA, 02142

View on SEC.gov